• Revenue up 16% to $15.3m
• Profit before tax up 7% to $3.4m
• Strong international sales, with Canada, Belgium and Germany delivering robust performance
• Demand for Orbis crushers remains strong, with crusher sales up 100% YoY

XRF Scientific Ltd ('XRF' or 'The Company') has provided an update on its September 2025 quarterly financial results (unaudited). The September 2025 quarter was a positive period, with all divisions contributing to the result. Revenue for the quarter was $15.3m, up 16% from $13.1m in the previous corresponding period (PCP). Profit before tax was $3.4m, up 7% from $3.2m in the PCP. International sales were strong, with the company's offices in Canada, Belgium and Germany delivering a robust performance. Consumable sales were $4.4m for the quarter compared to $4.6m in the PCP, with sample analysis activity across mining production and exploration continuing to drive sales. Domestic sales remain steady, with international sales expected to be the main driver of growth in FY26. Sales of capital equipment products were $5.0m compared to $4.3m in the PCP, with demand for Orbis crushers remaining strong and growth occurring in Australia and internationally. Orbis continues to gain market share, with crusher sales of $1.4m during the quarter, compared to $0.7m in the PCP. Precious metals product sales were $5.9m for the quarter compared to $4.3m in the PCP, with the company's recurring revenue base continuing to grow as additional fusion machine installations result in demand for platinum labware recycling. The company expects the December 2025 quarter to be positive for all divisions, with a focus on international sales growth, new product developments and M&A opportunities.

The company expects the December 2025 quarter to be positive for all divisions, with a focus on international sales growth, new product developments and M&A opportunities.